A Clinical Study of Pyrotinib in Patients With HER2-positive Advanced Colorectal Cancer

Status:
Recruiting

Trial end date:
2022-06-17

Target enrollment:

Participant gender:

To Observe the Efficacy and Safety of Pyrotinib Maleate in Patients With HER2-positive Advanced Colorectal Cancer

Phase 2

Second Affiliated Hospital, School of Medicine, Zhejiang University

First Affiliated Hospital of Zhejiang University
Sir Run Run Shaw Hospital
Zhejiang Cancer Hospital
Zhejiang Provincial People's Hospital

Trastuzumab